search
Back to results

Unravelling the Etiology of Shoulder Osteoarthritis (UESOA)

Primary Purpose

Osteoarthritis of the Shoulder

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Low-dose CT
T1Rho MRI
Motion Analysis
Sponsored by
Ottawa Hospital Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Osteoarthritis of the Shoulder focused on measuring T1Rho MRI, qCT, Motion Analysis

Eligibility Criteria

18 Years - 59 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults <60 years of age
  • Posterior humeral head subluxation >55% (determined from imaging)

Exclusion Criteria:

  • >60 years of age
  • History of shoulder instability
  • History of shoulder trauma including fracture
  • Neurological disorders of the upper limb
  • Imaging evidence of humeral head or glenoid bony deformity
  • Rotator cuff pathology
  • Labral pathology
  • Pre-existing joint deformity (OA) cases greater than grade I (as per Samilson and Prieto)

Sites / Locations

  • University of Ottawa
  • Carleton University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group 1: Early Degeneration ('Disease')

Group 2: No Degeneration ('Healthy')

Arm Description

Those who have posterior subluxation of the humeral head and show early signs of degeneration in their shoulder.

Those who have posterior subluxation of the humeral head and show no signs of degeneration.

Outcomes

Primary Outcome Measures

T1Rho MRI
MRI will be used to measure the muscle-fat ratio, and tendon thickness. Increased fat-infiltration, and tendon thinning indicates a worse outcome.
qCT (Low Dose CT)
Used to measure bone loss and density. Increased bone loss, and decreased density indicate a worse outcome.
Motion Analysis
A kinematic evaluation of the shoulder while performing functional tasks will help us determine how the rotator cuff muscle imbalance influences the shoulder joint kinematics.
Finite Element Analysis
This will be combined with motion analysis results to gain a better understanding of the internal loading within the tissues of the joint that could explain degenerative changes observed by imaging. Increased stresses, and muscle imbalance result in a worse outcome.

Secondary Outcome Measures

Full Information

First Posted
November 12, 2020
Last Updated
April 19, 2022
Sponsor
Ottawa Hospital Research Institute
Collaborators
University of Ottawa
search

1. Study Identification

Unique Protocol Identification Number
NCT04634773
Brief Title
Unravelling the Etiology of Shoulder Osteoarthritis
Acronym
UESOA
Official Title
Unravelling the Etiology of Shoulder Osteoarthritis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Enrolling by invitation
Study Start Date
June 23, 2021 (Actual)
Primary Completion Date
December 2026 (Anticipated)
Study Completion Date
December 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ottawa Hospital Research Institute
Collaborators
University of Ottawa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Osteoarthritis (OA) is a progressive disease resulting from the degradation of synovial joint articular cartilage over time. The hallmark symptom is diffuse aching and progressive pain made worse with activity. Loss of range of motion and compromised function inevitably follow. This degenerative disease can affect the shoulder joint. When symptoms become refractory to conservative treatment such as anti-inflammatory medication, steroid injections, activity modification or physical therapy; surgery (total or reverse shoulder arthroplasty) may be considered. Idiopathic shoulder OA is typically characterized by posterior subluxation of the humeral head upon the glenoid and posterior bone loss. An imbalance in the application of forces applied to the proximal humerus by the posterior and anterior rotator cuff muscles has been postulated to be the leading cause of idiopathic shoulder OA. However, there is only preliminary evidence to support this theory and the etiology of this pattern of deformity is unknown. The theory the posterior humeral head subluxation is a precursor to OA is only supported by very low-level evidence and no longitudinal studies have been conducted. As a result, the cause and natural history of shoulder OA remains unknown. Research into this area is urgently needed to generate knowledge that will inform future treatments aimed at modifying and slowing the progression of shoulder OA and to reduce the need for shoulder replacement therapy. The aim of this project is to develop an understanding of the pathophysiology of shoulder OA.
Detailed Description
Purpose: The aim of this project is to develop an understanding of the pathophysiology of shoulder OA. This project will recruit two groups of 30 participants, (60 participants in total) and follow them over a period of 5-years. Group 1- Participants with posterior subluxation of the humeral head and show early signs of degeneration in their shoulder 'disease group' Group 2- Participants with posterior subluxation of the humeral head and show no signs of degeneration 'control/healthy' group Hypotheses: The investigators hypothesize that there are several factors that contribute to the development of shoulder OA. Uncovering those pathways will lead to more targeted therapy. (1) The posterior rotator cuff muscles (infraspinatus/teres minor) apply relatively greater force than the anterior (subscapularis) cuff; an imbalance in the force couple occurs and the humeral head translates posteriorly on the glenoid; progressive posterior subluxation of the humeral head occurs and degeneration of the glenoid and humeral head cartilage follow. (2) Posterior subluxation of the humeral head is associated with progressive cartilage proteoglycan loss. (3) Pre-morbid glenoid morphology including increased retroversion is associated with the development of shoulder OA. Participant Involvement: The following will be completed with participants: T1Rho Magnetic Resonance Imaging (MRI), quantitative Computed Tomography (qCT), functional and motion analysis at baseline, year 2 and year 4 in the 'affected' shoulder in both groups 1 and 2. These tests will also be conducted on the asymptomatic, contralateral shoulder in Group 1 participants at baseline and year 4. The finite element model validation will be performed in years 2 and 3, and participant-specific finite element analysis (which has no active participant involvement) will occur in years 3 to 5. Overall study analysis will occur in year 5. This project will be done in two-parts. The first part will consist of six participants; assuming further funding is obtained, part two of the study will proceed. The second part of the project will be based on successfully obtaining funds to continue the remainder of the study recruitment (54 participants) and testing. As pilot data is urgently needed to secure granting funds to support this overall project, the investigators will commence with recruiting the first 6 participants. Once further funds are secured, the remaining portion (recruitment of 54 participants) of the project will continue. Objectives: (1) Determine whether patients with posterior humeral head subluxation have an imbalance between the posterior and anterior rotator cuff muscles. Objective 1 will be assessed through T1Rho MRI, and functional testing/motion analysis. (2) Determine whether patients with static posterior subluxation of the humeral head are at risk of degenerative changes (i.e. proteoglycan loss). Objective 2 will be assessed through T1Rho MRI and qCT scans. (3) Determine which joint factors are associated with progression of OA. This will be assessed using qCT scans and finite element model analysis. Clinical Relevance: The cause is shoulder OA is unknown, and the burden and costs associated with this degenerative disease are increasing with our aging population. Research in this area is urgently needed to generate knowledge which will inform future treatments which may modify and slow the progression of shoulder OA, and to reduce the need for shoulder replacement therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis of the Shoulder
Keywords
T1Rho MRI, qCT, Motion Analysis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1: Early Degeneration ('Disease')
Arm Type
Experimental
Arm Description
Those who have posterior subluxation of the humeral head and show early signs of degeneration in their shoulder.
Arm Title
Group 2: No Degeneration ('Healthy')
Arm Type
Active Comparator
Arm Description
Those who have posterior subluxation of the humeral head and show no signs of degeneration.
Intervention Type
Radiation
Intervention Name(s)
Low-dose CT
Intervention Description
A low-dose, or quantitative (q) CT scan will be performed on the shoulder. This CT scan will be done to assess the bony structure of the shoulder, as well as bone strength, which can influence the health of the cartilage. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years.
Intervention Type
Other
Intervention Name(s)
T1Rho MRI
Intervention Description
A T1Rho MRI will be performed on the shoulder. This imaging technique uses a special sequence and will be used to assess the muscles and tendons around the shoulder. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years.
Intervention Type
Other
Intervention Name(s)
Motion Analysis
Intervention Description
Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years.
Primary Outcome Measure Information:
Title
T1Rho MRI
Description
MRI will be used to measure the muscle-fat ratio, and tendon thickness. Increased fat-infiltration, and tendon thinning indicates a worse outcome.
Time Frame
5-Years Post-Allocation
Title
qCT (Low Dose CT)
Description
Used to measure bone loss and density. Increased bone loss, and decreased density indicate a worse outcome.
Time Frame
5-Years Post-Allocation
Title
Motion Analysis
Description
A kinematic evaluation of the shoulder while performing functional tasks will help us determine how the rotator cuff muscle imbalance influences the shoulder joint kinematics.
Time Frame
5-Years Post-Allocation
Title
Finite Element Analysis
Description
This will be combined with motion analysis results to gain a better understanding of the internal loading within the tissues of the joint that could explain degenerative changes observed by imaging. Increased stresses, and muscle imbalance result in a worse outcome.
Time Frame
5-Years Post-Allocation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults <60 years of age Posterior humeral head subluxation >55% (determined from imaging) Exclusion Criteria: >60 years of age History of shoulder instability History of shoulder trauma including fracture Neurological disorders of the upper limb Imaging evidence of humeral head or glenoid bony deformity Rotator cuff pathology Labral pathology Pre-existing joint deformity (OA) cases greater than grade I (as per Samilson and Prieto)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Lapner, MD, FRCSC
Organizational Affiliation
The Ottawa Hospital Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ottawa
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1N 6N5
Country
Canada
Facility Name
Carleton University
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1S5B6
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Unravelling the Etiology of Shoulder Osteoarthritis

We'll reach out to this number within 24 hrs